Gambhari (Gmelina arborea) ↔ Root-Fruit Divergent Pharmacology and Market-Secured Conservation

Gambhari's root and fruit carry opposite classical potencies and opposite uses, and the tree is also one of the very few Ayurvedic medicinal plants secured against overharvesting, because a large plywood industry cultivates it independently of medicinal demand.

IN PLAIN LANGUAGE

Gambhari is unusual: its root and its fruit are classed as having opposite properties and are used for opposite conditions, the root for vata (pain, stiffness) disorders as part of the dashamoola group of ten roots, and the cooling fruit for bleeding disorders. It is also one of the few Ayurvedic medicinal trees not at risk of overharvesting, because it is separately grown at large scale for plywood.

Ayurveda offers a long-standing formulary role for gambhari in both pain (dashamoola) and bleeding conditions. Modern forestry and conservation science offer a genuinely reassuring fact: because this tree is grown commercially for timber, its medicinal supply is secure in a way that many other Ayurvedic herbs, threatened by overharvesting, are not.

WHEN TO SEEK CARE

See a doctor for any significant or recurrent bleeding, or for pain with warning signs such as numbness, weakness, or loss of bladder or bowel control, rather than relying on gambhari-based remedies alone; these need proper diagnosis.

🔴 REFER IMMEDIATELY

Bleeding symptoms (epistaxis, menorrhagia, haematemesis, malaena) treated with gambhari phala or other raktapittahara dravyas without evaluation for a structural or haematological cause
Chronic or progressive neuropathic/musculoskeletal pain treated with dashamoola-based formulations without excluding a serious spinal or neurological cause
Any profuse, recurrent, or anaemia-associated bleeding treated symptomatically without workup
Any significant or recurrent bleeding (raktapitta-type presentation)
Progressive neurological deficit, saddle anaesthesia, or bladder/bowel dysfunction accompanying vata-type back or leg pain
Pain or bleeding not responding to standard treatment within an expected timeframe

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Gambhari mula within dashamoola-based kwatha or formulations for uncomplicated vata-type musculoskeletal pain, and gambhari phala for mild raktapitta-type symptoms, at classical doses, once serious causes are reasonably excluded.

MODERN MEDICINE SCOPE

Diagnostic workup of significant or recurrent bleeding, and of progressive or red-flag musculoskeletal/neurological pain, including imaging and specialist referral as indicated.

COLLABORATIVE SCOPE

Gambhari-containing dashamoola formulations can be used as a well-tolerated adjunct for uncomplicated vata-type pain or mild raktapitta symptoms once red-flag features have been excluded by standard evaluation.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.